76 related articles for article (PubMed ID: 21903335)
1. Hexameric immunoglobulin M in humans: desired or unwanted?
Petrušić V; Živković I; Stojanović M; Stojićević I; Marinković E; Dimitrijević L
Med Hypotheses; 2011 Dec; 77(6):959-61. PubMed ID: 21903335
[TBL] [Abstract][Full Text] [Related]
2. Structural and functional analysis of J chain-deficient IgM.
Wiersma EJ; Collins C; Fazel S; Shulman MJ
J Immunol; 1998 Jun; 160(12):5979-89. PubMed ID: 9637512
[TBL] [Abstract][Full Text] [Related]
3. Production of IgM hexamers by normal and autoimmune B cells: implications for the physiologic role of hexameric IgM.
Hughey CT; Brewer JW; Colosia AD; Rosse WF; Corley RB
J Immunol; 1998 Oct; 161(8):4091-7. PubMed ID: 9780180
[TBL] [Abstract][Full Text] [Related]
4. Differential activation of human and guinea pig complement by pentameric and hexameric IgM.
Collins C; Tsui FW; Shulman MJ
Eur J Immunol; 2002 Jun; 32(6):1802-10. PubMed ID: 12115664
[TBL] [Abstract][Full Text] [Related]
5. The biological effects of IgM hexamer formation.
Randall TD; King LB; Corley RB
Eur J Immunol; 1990 Sep; 20(9):1971-9. PubMed ID: 2120070
[TBL] [Abstract][Full Text] [Related]
6. Antigenic specificity and expression of a natural idiotope on human pentameric and hexameric IgM polymers.
Petrušić V; Zivković I; Stojanović M; Stojićević I; Marinković E; Inić-Kanada A; Dimitijević L
Immunol Res; 2011 Oct; 51(1):97-107. PubMed ID: 21786026
[TBL] [Abstract][Full Text] [Related]
7. Changes in composition of IgM polymers in patients suffering from recurrent urinary bacterial infections after bacterial immunization treatment.
Petrušić V; Stojanović M; Zivković I; Inić-Kanada A; Dimitrijević L
Immunol Invest; 2010; 39(8):781-95. PubMed ID: 20718658
[TBL] [Abstract][Full Text] [Related]
8. IgM and its receptors: structural and functional aspects.
Klimovich VB
Biochemistry (Mosc); 2011 May; 76(5):534-49. PubMed ID: 21639833
[TBL] [Abstract][Full Text] [Related]
9. J chain synthesis and secretion of hexameric IgM is differentially regulated by lipopolysaccharide and interleukin 5.
Randall TD; Parkhouse RM; Corley RB
Proc Natl Acad Sci U S A; 1992 Feb; 89(3):962-6. PubMed ID: 1736312
[TBL] [Abstract][Full Text] [Related]
10. IgM hexamers?
Brewer JW; Randall TD; Parkhouse RM; Corley RB
Immunol Today; 1994 Apr; 15(4):165-8. PubMed ID: 8198707
[TBL] [Abstract][Full Text] [Related]
11. At Critically Low Antigen Densities, IgM Hexamers Outcompete Both IgM Pentamers and IgG1 for Human Complement Deposition and Complement-Dependent Cytotoxicity.
Oskam N; Ooijevaar-de Heer P; Derksen NIL; Kruithof S; de Taeye SW; Vidarsson G; Reijm S; Kissel T; Toes REM; Rispens T
J Immunol; 2022 Jul; 209(1):16-25. PubMed ID: 35705253
[TBL] [Abstract][Full Text] [Related]
12. Polymerization of IgA and IgM: roles of Cys309/Cys414 and the secretory tailpiece.
Sørensen V; Sundvold V; Michaelsen TE; Sandlie I
J Immunol; 1999 Mar; 162(6):3448-55. PubMed ID: 10092800
[TBL] [Abstract][Full Text] [Related]
13. On the structure of polymeric IgM.
Davis AC; Roux KH; Shulman MJ
Eur J Immunol; 1988 Jul; 18(7):1001-8. PubMed ID: 3136022
[TBL] [Abstract][Full Text] [Related]
14. J chain deficiency in human IgM monoclonal antibodies produced by Epstein-Barr virus-transformed B lymphocytes.
Meng YG; Criss AB; Georgiadis KE
Eur J Immunol; 1990 Nov; 20(11):2505-8. PubMed ID: 2174785
[TBL] [Abstract][Full Text] [Related]
15. Neutralization of vesicular stomatitis virus (VSV) by human complement requires a natural IgM antibody present in human serum.
Beebe DP; Cooper NR
J Immunol; 1981 Apr; 126(4):1562-8. PubMed ID: 6259260
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human hexamer-dominant IgM monoclonal antibody to ganglioside GM3 for treatment of melanoma.
Azuma Y; Ishikawa Y; Kawai S; Tsunenari T; Tsunoda H; Igawa T; Iida S; Nanami M; Suzuki M; Irie RF; Tsuchiya M; Yamada-Okabe H
Clin Cancer Res; 2007 May; 13(9):2745-50. PubMed ID: 17473208
[TBL] [Abstract][Full Text] [Related]
17. C4 does not bind to human and rabbit IgM during activation of the classical complement pathway on the red cell.
Circolo A; Borsos T
J Immunol; 1982 Oct; 129(4):1485-8. PubMed ID: 7108214
[TBL] [Abstract][Full Text] [Related]
18. Late events in assembly determine the polymeric structure and biological activity of secretory IgM.
Brewer JW; Corley RB
Mol Immunol; 1997 Mar; 34(4):323-31. PubMed ID: 9244345
[TBL] [Abstract][Full Text] [Related]
19. IgM expressed by leukemic CD5(+) B cells binds mouse immunoglobulin light chain.
Weston KM; Tangye SG; Dunn RD; Smith A; Morris MB; Raison RL
J Mol Recognit; 2001; 14(4):245-53. PubMed ID: 11500971
[TBL] [Abstract][Full Text] [Related]
20. Direct evidence that J chain regulates the polymeric structure of IgM in antibody-secreting B cells.
Randall TD; Brewer JW; Corley RB
J Biol Chem; 1992 Sep; 267(25):18002-7. PubMed ID: 1517233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
